BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration...
United States Francesca Demartino Troy Kirkpatrick Administration For Strategic Preparedness Us Department Of Health Development Authority
Source: prnewswire.com